Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2024

Open Access 01-12-2024 | Gout | Research

Relationship between gout, hyperuricemia, and obesity—does central obesity play a significant role?—a study based on the NHANES database

Authors: Tongjun Mao, Qian He, Junping Yang, Lanlan Jia, Guofei Xu

Published in: Diabetology & Metabolic Syndrome | Issue 1/2024

Login to get access

Abstract

Background

Our objective was to evaluate how various measures of obesity, such as body mass index(BMI), body roundness index(BRI), and weigh adjusted waist index(WWI), influence urate levels, prevalence of gout and to compare the disparities among these obesity indicators.

Methods

By analyzing the 2001–2018 National Health and Nutrition Examination Survey (NHANES), we assessed the relationship between BMI, WWI, and BRI indices and urate levels, hyperuricemia, and the prevalence of gout. Smoothed curve fitting was used to determine whether there was a nonlinear relationship between BMI,WWI, and BRI indices and urate levels, hyperuricemia, and the prevalence of gout, and threshold effects analysis was used to test this relationship. We also used ROC curves to determine the diagnostic efficacy of BMI, WWI, and BRI on the prevalence of hyperuricemia and gout.

Results

The study incorporated a total of 29,310 participants aged over 20 years, out of which 14,268 were male. Following the adjustment for the pertinent confounding factors, it was observed that higher levels of BMI, WWI, and BRI were significantly associated with a gradual and dose-dependent increase in urate levels. In the sensitivity analysis, each unit increment in BMI, WWI, and BRI levels exhibited an 8%, 72%, and 26% respective elevation in the risk of hyperuricemia, as well as a 5%, 31%, and 15% respective increase in the risk of gout. Dose-response curves provided evidence of a linear positive correlation between BMI, WWI, BRI, and urate levels, as well as the prevalence of hyperuricemia and gout. Based on the response from the ROC curve, overall, the diagnostic efficacy of BRI for hyperuricemia and gout surpasses that of BMI.

Conclusion

The central obesity indices WWI and BRI levels are superior to BMI in detecting the prevalence of urate levels, hyperuricemia, and gout, and although a clear causal relationship has not yet been established, it is important to recognize the impact of central obesity on uric acid levels and to give it due attention.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–90.PubMedCrossRef Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol. 2020;16(7):380–90.PubMedCrossRef
2.
go back to reference Fraser SD, Roderick PJ, May CR, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2015;16:193.PubMedPubMedCentralCrossRef Fraser SD, Roderick PJ, May CR, et al. The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol. 2015;16:193.PubMedPubMedCentralCrossRef
3.
go back to reference Li Q, Li X, Wang J, et al. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019;9(8):e026677.PubMedPubMedCentralCrossRef Li Q, Li X, Wang J, et al. Diagnosis and treatment for hyperuricemia and gout: a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019;9(8):e026677.PubMedPubMedCentralCrossRef
4.
go back to reference Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):11–S16.CrossRef Singh JA, Gaffo A. Gout epidemiology and comorbidities. Semin Arthritis Rheum. 2020;50(3S):11–S16.CrossRef
5.
go back to reference Rho YH, Lu N, Peloquin CE, et al. Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2016;75(1):91–5.PubMedCrossRef Rho YH, Lu N, Peloquin CE, et al. Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2016;75(1):91–5.PubMedCrossRef
6.
7.
go back to reference Roughley MJ, Belcher J, Mallen CD, Roddy E. Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther. 2015;17(1):90.PubMedPubMedCentralCrossRef Roughley MJ, Belcher J, Mallen CD, Roddy E. Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies. Arthritis Res Ther. 2015;17(1):90.PubMedPubMedCentralCrossRef
8.
go back to reference Chang K, Yokose C, Tenner C, et al. Association between gout and aortic stenosis. Am J Med. 2017;130(2):230.e1–230.e8.CrossRef Chang K, Yokose C, Tenner C, et al. Association between gout and aortic stenosis. Am J Med. 2017;130(2):230.e1–230.e8.CrossRef
9.
10.
go back to reference Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. 2015;74(4):642–7.PubMedCrossRef Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. 2015;74(4):642–7.PubMedCrossRef
11.
go back to reference Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis. 2013;231(1):61–8.PubMedCrossRef Zhao G, Huang L, Song M, Song Y. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis. 2013;231(1):61–8.PubMedCrossRef
12.
go back to reference Nozue T, Yamamoto S, Tohyama S, et al. Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy. Coron Artery Dis. 2014;25(4):343–8.PubMedCrossRef Nozue T, Yamamoto S, Tohyama S, et al. Correlations between serum uric acid and coronary atherosclerosis before and during statin therapy. Coron Artery Dis. 2014;25(4):343–8.PubMedCrossRef
13.
go back to reference Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2014;11(7):1102–8.PubMedCrossRef Tamariz L, Hernandez F, Bush A, Palacio A, Hare JM. Association between serum uric acid and atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2014;11(7):1102–8.PubMedCrossRef
14.
go back to reference Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(7):885–92.PubMedPubMedCentralCrossRef Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(7):885–92.PubMedPubMedCentralCrossRef
15.
go back to reference Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63(1):102–10.PubMedCrossRef Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2011;63(1):102–10.PubMedCrossRef
16.
go back to reference Viazzi F, Rebora P, Giussani M, et al. Increased serum uric acid levels Blunt the Antihypertensive efficacy of lifestyle modifications in children at Cardiovascular Risk. Hypertension. 2016;67(5):934–40.PubMedCrossRef Viazzi F, Rebora P, Giussani M, et al. Increased serum uric acid levels Blunt the Antihypertensive efficacy of lifestyle modifications in children at Cardiovascular Risk. Hypertension. 2016;67(5):934–40.PubMedCrossRef
17.
go back to reference Cicero AF, Rosticci M, Fogacci F, Grandi E, D’Addato S, Borghi C. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. Eur J Intern Med. 2017;37:38–42.PubMedCrossRef Cicero AF, Rosticci M, Fogacci F, Grandi E, D’Addato S, Borghi C. High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects. Eur J Intern Med. 2017;37:38–42.PubMedCrossRef
18.
go back to reference Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122.PubMedPubMedCentralCrossRef Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease? A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122.PubMedPubMedCentralCrossRef
19.
go back to reference Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS ONE. 2013;8(2):e56864.PubMedPubMedCentralCrossRef Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS ONE. 2013;8(2):e56864.PubMedPubMedCentralCrossRef
20.
go back to reference Yu TY, Jee JH, Bae JC, et al. Serum uric acid: a strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism. 2016;65(4):432–40.PubMedCrossRef Yu TY, Jee JH, Bae JC, et al. Serum uric acid: a strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism. 2016;65(4):432–40.PubMedCrossRef
21.
go back to reference Saxton JM, Pickering K, Wane S, et al. Co-designed weight management intervention for women recovering from oestrogen-receptor positive breast cancer. BMC Cancer. 2022;22(1):1202.PubMedPubMedCentralCrossRef Saxton JM, Pickering K, Wane S, et al. Co-designed weight management intervention for women recovering from oestrogen-receptor positive breast cancer. BMC Cancer. 2022;22(1):1202.PubMedPubMedCentralCrossRef
22.
go back to reference da Silva SB, Editorial, Comment. Effect of a low-calorie diet on 24-hour urinary parameters of obese adults with idiopathic calcium oxalate kidney stones. Int Braz J Urol. 2021;47(6):1148–9.PubMedPubMedCentralCrossRef da Silva SB, Editorial, Comment. Effect of a low-calorie diet on 24-hour urinary parameters of obese adults with idiopathic calcium oxalate kidney stones. Int Braz J Urol. 2021;47(6):1148–9.PubMedPubMedCentralCrossRef
23.
go back to reference Choi HK, McCormick N, Lu N, Rai SK, Yokose C, Zhang Y. Population Impact Attributable to modifiable risk factors for Hyperuricemia. Arthritis Rheumatol. 2020;72(1):157–65.PubMedCrossRef Choi HK, McCormick N, Lu N, Rai SK, Yokose C, Zhang Y. Population Impact Attributable to modifiable risk factors for Hyperuricemia. Arthritis Rheumatol. 2020;72(1):157–65.PubMedCrossRef
25.
go back to reference Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005;165(7):742–8.PubMedCrossRef Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005;165(7):742–8.PubMedCrossRef
26.
go back to reference Yeo C, Kaushal S, Lim B, et al. Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis. Obes Rev. 2019;20(12):1759–70.PubMedCrossRef Yeo C, Kaushal S, Lim B, et al. Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis. Obes Rev. 2019;20(12):1759–70.PubMedCrossRef
27.
go back to reference Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57(1):109–15.PubMedCrossRef Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum. 2007;57(1):109–15.PubMedCrossRef
28.
go back to reference Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105–20.PubMedCrossRef Pischon T, Boeing H, Hoffmann K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105–20.PubMedCrossRef
29.
go back to reference Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.PubMedCrossRef Whitlock G, Lewington S, Sherliker P, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373(9669):1083–96.PubMedCrossRef
31.
go back to reference Vasudevan A, Thomas T, Kurpad A, Sachdev HS. Prevalence of and factors Associated with High Blood pressure among adolescents in India. JAMA Netw Open. 2022;5(10):e2239282.PubMedPubMedCentralCrossRef Vasudevan A, Thomas T, Kurpad A, Sachdev HS. Prevalence of and factors Associated with High Blood pressure among adolescents in India. JAMA Netw Open. 2022;5(10):e2239282.PubMedPubMedCentralCrossRef
32.
go back to reference Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obes (Silver Spring). 2013;21(11):2264–71.CrossRef Thomas DM, Bredlau C, Bosy-Westphal A, et al. Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model. Obes (Silver Spring). 2013;21(11):2264–71.CrossRef
33.
go back to reference Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep. 2018;8(1):16753.PubMedPubMedCentralCrossRef Park Y, Kim NH, Kwon TY, Kim SG. A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality. Sci Rep. 2018;8(1):16753.PubMedPubMedCentralCrossRef
34.
go back to reference Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):14–80. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):14–80.
35.
go back to reference Lee HJ, Choi JY, Lee J, Kim D, Min JY, Min KB. Association between serum uric acid and α-klotho protein levels in the middle-aged population. Aging. 2022;14(6):2537–47.PubMedPubMedCentralCrossRef Lee HJ, Choi JY, Lee J, Kim D, Min JY, Min KB. Association between serum uric acid and α-klotho protein levels in the middle-aged population. Aging. 2022;14(6):2537–47.PubMedPubMedCentralCrossRef
36.
go back to reference Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961–1980. Arthritis Rheum. 1983;26(1):87–93.PubMedCrossRef Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961–1980. Arthritis Rheum. 1983;26(1):87–93.PubMedCrossRef
37.
go back to reference Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism. 1997;46(10):1162–5.PubMedCrossRef Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism. 1997;46(10):1162–5.PubMedCrossRef
38.
go back to reference Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47(8):929–33.PubMedCrossRef Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47(8):929–33.PubMedCrossRef
39.
go back to reference Shirasawa T, Ochiai H, Yoshimoto T, et al. Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan. BMC Endocr Disord. 2020;20(1):2.PubMedPubMedCentralCrossRef Shirasawa T, Ochiai H, Yoshimoto T, et al. Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan. BMC Endocr Disord. 2020;20(1):2.PubMedPubMedCentralCrossRef
40.
go back to reference Huang ZP, Huang BX, Zhang H, Zhu MF, Zhu HL. Waist-to-height ratio is a better predictor of Hyperuricemia than Body Mass Index and Waist circumference in Chinese. Ann Nutr Metab. 2019;75(3):187–94.PubMedCrossRef Huang ZP, Huang BX, Zhang H, Zhu MF, Zhu HL. Waist-to-height ratio is a better predictor of Hyperuricemia than Body Mass Index and Waist circumference in Chinese. Ann Nutr Metab. 2019;75(3):187–94.PubMedCrossRef
41.
go back to reference Kim TH, Lee SS, Yoo JH, et al. The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr. 2012;4(1):3.PubMedPubMedCentralCrossRef Kim TH, Lee SS, Yoo JH, et al. The relationship between the regional abdominal adipose tissue distribution and the serum uric acid levels in people with type 2 diabetes mellitus. Diabetol Metab Syndr. 2012;4(1):3.PubMedPubMedCentralCrossRef
42.
go back to reference Ding Y, Xu Z, Zhou X, Luo Y, Xie R, Li Y. Association between weight-adjusted-waist index and the risk of hyperuricemia in adults: a population-based investigation. Front Endocrinol (Lausanne). 2023;14:1236401.PubMedCrossRef Ding Y, Xu Z, Zhou X, Luo Y, Xie R, Li Y. Association between weight-adjusted-waist index and the risk of hyperuricemia in adults: a population-based investigation. Front Endocrinol (Lausanne). 2023;14:1236401.PubMedCrossRef
43.
go back to reference Martínez-Montoro JI, Morales E, Cornejo-Pareja I, Tinahones FJ, Fernández-García JC. Obesity-related glomerulopathy: current approaches and future perspectives. Obes Rev. 2022;23(7):e13450.PubMedPubMedCentralCrossRef Martínez-Montoro JI, Morales E, Cornejo-Pareja I, Tinahones FJ, Fernández-García JC. Obesity-related glomerulopathy: current approaches and future perspectives. Obes Rev. 2022;23(7):e13450.PubMedPubMedCentralCrossRef
44.
go back to reference Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764.PubMedCrossRef Ichida K, Matsuo H, Takada T, et al. Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun. 2012;3:764.PubMedCrossRef
45.
go back to reference Shen X, Chen Y, Chen Y, Liang H, Li G, Hao Z. Is the METS-IR index a potential new biomarker for kidney Stone Development. Front Endocrinol (Lausanne). 2022;13:914812.PubMedCrossRef Shen X, Chen Y, Chen Y, Liang H, Li G, Hao Z. Is the METS-IR index a potential new biomarker for kidney Stone Development. Front Endocrinol (Lausanne). 2022;13:914812.PubMedCrossRef
46.
47.
go back to reference Gong M, Wen S, Nguyen T, Wang C, Jin J, Zhou L. Converging relationships of obesity and hyperuricemia with Special Reference to Metabolic disorders and plausible therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:943–62.PubMedPubMedCentralCrossRef Gong M, Wen S, Nguyen T, Wang C, Jin J, Zhou L. Converging relationships of obesity and hyperuricemia with Special Reference to Metabolic disorders and plausible therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:943–62.PubMedPubMedCentralCrossRef
48.
go back to reference Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008;47(13):1175–80.PubMedCrossRef Tamba S, Nishizawa H, Funahashi T, et al. Relationship between the serum uric acid level, visceral fat accumulation and serum adiponectin concentration in Japanese men. Intern Med. 2008;47(13):1175–80.PubMedCrossRef
49.
go back to reference Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfützner A. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism. 1999;48(6):677–80.PubMedCrossRef Fruehwald-Schultes B, Peters A, Kern W, Beyer J, Pfützner A. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism. 1999;48(6):677–80.PubMedCrossRef
Metadata
Title
Relationship between gout, hyperuricemia, and obesity—does central obesity play a significant role?—a study based on the NHANES database
Authors
Tongjun Mao
Qian He
Junping Yang
Lanlan Jia
Guofei Xu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2024
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-024-01268-1

Other articles of this Issue 1/2024

Diabetology & Metabolic Syndrome 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.